Francisco Javier Rodríguez-Baena

4PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 10, 2023
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Marta Redondo-Muñoz, Francisco Javier Rodriguez-Baena, Paula Aldaz

|Jul 29, 2023
Microenvironmental Snail1-induced immunosuppression promotes melanoma growth.

Marta Arumi-Planas, Francisco Javier Rodriguez-Baena, Francisco Cabello-Torres

|May 13, 2023
Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.

Carlos Costas-Insua, Marta Seijo-Vila, Cristina Blázquez

|Sep 01, 2018
ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response.

Francisco Javier Rodríguez-Baena, Silvia Redondo-García, Carlos Peris-Torres

Pageof 1

Frequent Collaborators

2 joint publications

Berta Sanchez-Laorden

1 joint publications

Rubén Fernández-Rodríguez

1 joint publications

Juan Carlos Rodríguez-Manzaneque

1 joint publications

Carlos Costas-Insua